Possible Benefits Of CBD Oil

The relationship between infection and traditional antibiotics

Could CBD work in the fight against resistant bacterial pressures? The arise from the University of Queensland in Australia recommend that it is possible. However prior to analyzing the study in depth, it is useful to understand the development of the relationship between germs and antibiotics.

Considering that the advanced discovery of penicillin by Alexander Fleming in 1928, antibiotics have been an important tool in the fight against germs and infections. And although we still use the very same proven techniques today, germs have evolved. When exposed to antibiotics, specific germs, fungi and parasites are able to adapt and cancel the efficiency of the drug by developing resistance.

It’s worth pointing out that antimicrobial resistance was likely to happen anyway, as the genetic code for germs changes over time. However, it is thought that the overuse of antibiotics is a crucial element that accelerates the development of resistant pressures.

According to the World Health Organization, antimicrobial resistance “is a significantly major risk to global public health that requires action in all sectors of government and in society.” This has actually led scientists to think outside the box by trying to recognize compounds that could be beneficial in the fight against harmful germs. Among these compounds is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Researchers are searching for brand-new methods to assault infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD works against Gram-positive germs. Pressures of Gram-positive germs include Staphylococcus aureus (typical in skin infections) and Streptococcus pneumoniae (typical in bacterial pneumonia).

Dr. Blaskovich provided his findings at an annual meeting of the American Society for Microbiology. In vitro samples of both types of gram-positive germs were treated with artificial CBD. The outcomes led Dr. Blaskovich to the conclusion that CBD works at levels similar to those of prescription antibiotics vancomycin and daptomycin. He also discovered that CBD appeared to work against gram-positive pressures of resistant germs, which numerous conventional antibiotics are beginning to fail.

” In particular, the activity was selected against the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low tendency to cause resistance and was active against MRSA biofilms. “

The group also performed another study using topical CBD to treat a skin infection in mice. Again, although the outcomes were positive, CBD did not appear to remove the infection, but merely to minimize the variety of bacterial cells.

Could CBD become an antibiotic?

While it is easy to hail this work as a significant breakthrough in the anti-bacterial abilities of CBD, it is prematurely to quit on penicillin.

Although it is thought that the efficiency of CBD might come from the way it assaults the biofilm surrounding bacterial cells, the authors are still uncertain of the system of action of CBD. They also did not think twice to point out the drawbacks of the study. Dr. Blaskovich explained that considering that the outcomes remain in the preliminary stages, it is far too early for people to begin treating their CBD stream infections themselves.

The study was also performed in vitro (outside the body), and there is a risk that the outcomes of medical trials will not be the same. Several compounds have revealed anti-bacterial efficacy in petri dishes, but then failed at this vital phase. It ought to also be discussed that the two research studies were carried out in cooperation with Botanix Pharmaceuticals Ltd, a pharmaceutical company concentrating on topical inner CBD products.

However, this research could be a crucial advance for CBD and the fight against antimicrobial resistance. CBD continues to have an excellent security profile and is ruled out toxic even in big quantities. Luckily, Dr. Blaskovich and his group plan to continue their research.

Scroll to top